• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.14% Nasdaq Down0.01%

    Myrexis, Inc. (MYRX)

    -Other OTC
    0.11 0.00(0.00%) 10:42AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Myrexis, Inc.
    630 Fifth Avenue
    Suite 2260
    New York, NY 10020
    United States - Map
    Phone: 801-214-7800
    Website: http://www.myrexis.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:1

    Business Summary 

    Myrexis, Inc., a biopharmaceutical company, focuses on identifying, evaluating, and acquiring commercial-stage biopharmaceutical assets. The company intends to acquire one or more commercial-stage biopharmaceutical assets. As of February 2012, it suspended development activities of all its preclinical and clinical programs in oncology and autoimmune diseases, and continues to pursue business development opportunities for each of its programs. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Myrexis, Inc.

    Key Executives 
    Mr. Jonathan M. Couchman CFA, 45
    Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Principal Accounting Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders